The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, L. X.
Right arrow Articles by Rottapel, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, L. X.
Right arrow Articles by Rottapel, R.
The Journal of Immunology, 2005, 174: 180-194.
Copyright © 2005 by The American Association of Immunologists

CD28 Regulates the Translation of Bcl-xL via the Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Pathway1

Linda X. Wu*,§, Jose La Rose§, Liane Chen{dagger},§, Chris Neale§, Tak Mak*,{dagger},§, Klaus Okkenhaug, Ronald Wange|| and Robert Rottapel2,*,{dagger},{ddagger},§,#

* Departments of Immunology, {dagger} Medical Biophysics, and {ddagger} Medicine, University of Toronto, Toronto, Ontario, Canada; § Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada; Babraham Institute, Babraham, Cambridge, United Kingdom; || Laboratory of Cellular and Molecular Biology National Institute on Aging, National Institutes of Health, Baltimore, MD 00000; and # St. Michael’s Hospital, Toronto, Ontario, Canada

In concert with the TCR, CD28 promotes T cell survival by regulating the expression of the antiapoptotic protein Bcl-xL. The mechanism by which CD28 mediates the induction of Bcl-xL remains unknown. We show that although signaling through the TCR is sufficient to stimulate transcription of Bcl-xL mRNA, CD28, by activating PI3K and mammalian target of rapamycin, provides a critical signal that regulates the translation of Bcl-xL transcripts. We observe that CD28 induced 4E-binding protein-1 phosphorylation, an inhibitor of the translational machinery, and that CD28 costimulation directly augmented the translation of a Bcl-xL 5'-untranslated region reporter construct. Lastly, costimulation by CD28 shifted the distribution of Bcl-xL mRNA transcripts from the pretranslation complex to the translationally active polyribosomes. These results demonstrate that CD28 relieves the translational inhibition of Bcl-xL in a PI3K/mammalian target of rapamycin-dependent manner.


Related articles in The JI:

IN THIS ISSUE

The JI 2005 174: 1-2. [Full Text]  



This article has been cited by other articles:


Home page
J. Immunol.Home page
J. R. F. Abreu, A. M. Grabiec, S. Krausz, R. Spijker, T. Burakowski, W. Maslinski, E. Eldering, P. P. Tak, and K. A. Reedquist
The Presumed Hyporesponsive Behavior of Rheumatoid Arthritis T Lymphocytes Can Be Attributed to Spontaneous Ex Vivo Apoptosis rather than Defects in T Cell Receptor Signaling
J. Immunol., July 1, 2009; 183(1): 621 - 630.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Xue, A. Barrow, and R. Pettipher
Novel Function of CRTH2 in Preventing Apoptosis of Human Th2 Cells through Activation of the Phosphatidylinositol 3-Kinase Pathway
J. Immunol., June 15, 2009; 182(12): 7580 - 7586.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Zhang, G. Tsaprailis, and G. T. Bowden
Nucleolin Stabilizes Bcl-XL Messenger RNA in Response to UVA Irradiation
Cancer Res., February 15, 2008; 68(4): 1046 - 1054.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Boller, A. Schramm, K. T. Doepfner, T. Shalaby, A. O. von Bueren, A. Eggert, M. A. Grotzer, and A. Arcaro
Targeting the Phosphoinositide 3-Kinase Isoform p110{delta} Impairs Growth and Survival in Neuroblastoma Cells
Clin. Cancer Res., February 15, 2008; 14(4): 1172 - 1181.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Mariotti, J. Foley, U. Jung, T. Borenstein, N. Kantardzic, S. Han, J. T. Hanson, E. Wong, N. Buxhoeveden, J. B. Trepel, et al.
Ex Vivo Rapamycin Generates Apoptosis-Resistant Donor Th2 Cells That Persist In Vivo and Prevent Hemopoietic Stem Cell Graft Rejection
J. Immunol., January 1, 2008; 180(1): 89 - 105.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-C. Su, Y.-P. Lin, Y.-J. Cheng, J.-Y. Huang, W.-J. Chuang, Y.-S. Shan, and B.-C. Yang
Phosphatidylinositol 3-Kinase/Akt Activation by Integrin-Tumor Matrix Interaction Suppresses Fas-Mediated Apoptosis in T Cells
J. Immunol., October 1, 2007; 179(7): 4589 - 4597.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. M. Kowolik, M. S. Topp, S. Gonzalez, T. Pfeiffer, S. Olivares, N. Gonzalez, D. D. Smith, S. J. Forman, M. C. Jensen, and L. J.N. Cooper
CD28 Costimulation Provided through a CD19-Specific Chimeric Antigen Receptor Enhances In vivo Persistence and Antitumor Efficacy of Adoptively Transferred T Cells.
Cancer Res., November 15, 2006; 66(22): 10995 - 11004.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Colombetti, V. Basso, D. L. Mueller, and A. Mondino
Prolonged TCR/CD28 Engagement Drives IL-2-Independent T Cell Clonal Expansion through Signaling Mediated by the Mammalian Target of Rapamycin.
J. Immunol., March 1, 2006; 176(5): 2730 - 2738.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. A. Abdelmegeed, N. J. Carruthers, K. J. Woodcroft, S. K. Kim, and R. F. Novak
Acetoacetate Induces CYP2E1 Protein and Suppresses CYP2E1 mRNA in Primary Cultured Rat Hepatocytes
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 203 - 213.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.